learn Follistatin
glycoprotein that inhibits TGF-β and promotes hair growth by antagonizing activin
Search
forProducts matching "phase i"
Tracking 8 products like 41 Minoxidil, 151 Tugain 5 Solution (Minoxidil 5%), 152 Tugain 10 Solution (Minoxidil 10%), 179 Tugain 5% 60ml and 250 Minoxidil 90 caps from by companies like Roman, Inhouse Pharmacy, ReliableRxpharmacy and MV supplements . View all 8 products »Learn
5 / 33 resultslearn Low Level Laser Therapy
laser therapy for anti-inflammatory and likely insignificant hair regrowth effects
learn Valproic acid
an anticonvulsant repurposed for hair loss via histone inhibition
learn Stemoxydine
chemical from L'Oreal that encourages hair to enter growth phase
learn Rapamycin
mTOR regulator and immunosuppressant used more recently for anti-aging and hair regrowth
Research
5 / 1000+ resultsresearch Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome
Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.
research Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors
The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.
research Phase I/II randomized bilateral half-head comparison of topical bexarotene 1% gel for alopecia areata
Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.
research Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
The drug combination was safe and showed promise in treating advanced tumors.
research Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment
Baricitinib is generally safe for long-term use in treating severe alopecia areata.
Community Join
5 / 1000+ resultscommunity Phase II topical dut study - outperforms oral fin with a minor DHT reduction
Topical dutasteride 0.05% is more effective for hair growth than oral finasteride 1mg, with minimal DHT reduction. The formulation uses castor oil and MCTs for better absorption but is not widely available until 2028.
community Phase II Clinical Trial for TDM-105795 started recruiting
A Phase II clinical trial for TDM-105795 has started recruiting in the US, and it might be a promising treatment for hair loss. Many hair loss drugs, including this one, originate from China.
community Phase II for Technoderma Therepeutic's TDM-105795 set to begin in April tentatively
Phase II for TDM-105795 for Androgenic Alopecia is set to begin in April 2023. The study aims to evaluate the efficacy and safety of TDM-105795 in male subjects.
community Pyrilutamide phase III clinical trial results released
Pyrilutamide did not show effectiveness in regrowing hair compared to a placebo, but it may still help maintain existing hair by preventing DHT from causing follicle miniaturization. Some users believe it could be beneficial when used with other treatments like minoxidil, finasteride, and dutasteride.
community About Pyrilutamide Phase II US Trial
The conversation discusses the comparison of Pyrilutamide Phase II US trial results with 1 mg finasteride for hair loss treatment. It mentions that the total hair count increase in the US trial was not as good as the China trial.